Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent plasma therapy in ICU patients with COVID-19
IRCT20200416047099N1Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2020
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Size of lesion area by chest CT scan, Recovery of clinical symptoms such as fever and respiratory rate and 1 more. Started Apr 2020; status: completed.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20200416047099N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200416047099N1.